Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
agitation
alcohol
alcohol, neurologic complications with
alcoholic withdrawal states, DT's, convulsions, etc.
amenorrhea
amphetamines
anticonvulsants
anxiety
benzodiazepine
benzodiazepine agonist
bromocriptine
Chiari Frommel syndrome
clonidine
cocaine
delirium
detoxification
drug induced neurologic disorders
drug withdrawal
empty sella syndrome
ergotamine
galactorrhea
hypothyroidism
lergotrile
menses
naltrexone
neoplasm, pituitary
neoplasm, pituitary, treatment of
opiate
oral contraceptives
phenothiazine
progressive supranuclear palsy
prolactin
prolactin, elevated
review article
seizure
seizure, treatment of
seizure, withdrawal
skull x-ray
skull x-ray, abnormal
treatment of neurologic disorder
visual field defect
zolpidem
Showing articles 300 to 350 of 488 << Previous Next >>

'De Novo'Absence Status of Late Onset:Report of 11 Cases
Neurol 42:104-110, Thomas,P.,et al, 1992

An Open-Label Trial of Bromocriptine in Nonfluent Aphasia
Neurol 42:1637-1638, Sabe,L.,et al, 1992

Treatment of Migraine
Lancet 339:1207-1209, Lance,J.W., 1992

Coronary Vasospasm Induced by Subcutaneous Sumatriptan
BMJ 304:1415, Willett,F.,et al, 1992

Dopamine Agonist Treatment of Fluctuating Parkinsonisn
Arch Neurol 49:560-568, Ahlskog,J.E.,et al, 1992

Acute Respiratory Failure from Dopamine Agonist Withdrawal
Neurol 42:1843-1844, Riley,D.E.,et al, 1992

Cerebral Venous Thrombosis
Neurol Clin 10:87-111, Ameri,A.&Bousser,M-G., 1992

Sumatriptan
Serotonin, Migraine, and Money, Editorial, Lancet 339:151-1522., , 1992

Endogenous Benzodiazepine Receptor Ligands in Idiopathic Recurring Stupor
Lancet 340:1002-1004, Rothstein,J.D.,et al, 1992

Sumatriptan:Efficacy and Contribution to Migraine Mechanisms
JNNP 55:1103-1105, Pearce,J.M.S., 1992

Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 47:1085-1087, Wolters,W.Ch.,et al, 1992

The Use of Sedative Agents in Critically Ill Patients
Drugs 43:507-515, Burns,A.M.,et al, 1992

Oral Sumatriptan in Acute Migraine
Lancet 338:782-783, Goadsby,P.J.,et al, 1991

A Multi-Center, Double-Blind Study on Slow-Release Bromocriptine in the Treatment of Parkinson's Disease
Neurol 41:1598-1602, Mannen,T.,et al, 1991

Pleuropulmonary Disease Associated with Dopamine Agonist Therapy
Ann Neurol 30:613-616, Bhatt,M.H.,et al, 1991

The Apomorphine Test in Parkinsonian Syndromes
JNNP 54:870-872, D'Costa,D.F.,et al, 1991

Treatment of Acute Migraine with Subcutaneous Sumatriptan
JAMA 265:2831-2835, Cady,R.K.,et al, 1991

Treatment of Migraine Attacks with Sumatriptan
The Subcutaneous Sumatriptan International Study Group, NEJM 325:316-321, 353-354991., , 1991

Migraine Pain Associated with Middle Cerebral Artery Dilatation:Reversal by Sumatriptan
Lancet 338:13-17, Friberg,L.,et al, 1991

Treatment of Acute Cluster Headache with Sumatriptan
The Sumatriptan Cluster Headache Study Group, NEJM 325:322-326, 353-354991., , 1991

Accelerated Intracranial Occlusive Disease, Oral Contraceptives, and Cigarette Use
Neurol 41:1893-1901, Levine,S.R.,et al, 1991

Sumatriptan in Migraine, May be Better than Aspirin and Metoclopramide
BMJ 303:1491, Pearce,J.M.S., 1991

Tourette Syndrome and Other Tic Disorders, Diagnosis, Pathophysiology, and Treatment
Medicine 70:15-32, Singer,H.S.&Walkup,J.T., 1991

Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991

Next-Day Memory Impairment with Triazolam Use
Lancet 337:827-831, Bixler,E.O.,et al, 1991

Cerebral Infarction in Young People, A Study of 148 Patients with Early Cerebral Angiography
JNNP 54:576-579, Lisovoski,F.&Rousseaux,P., 1991

Estrogens, Progestins, and Headache
Neurol 41:786-793, Silberstein,S.D.&Merriam,G.R., 1991

Elevated Brain Concentrations of 1, 4-Benzodiazepines in Fulminant Hepatic Failure
NEJM 325:473-478, 5091991., Basile,A.S.,et al, 1991

Adverse Drug Effects on Neuromuscular Transmission
Semin Neurol 10:89-102, Howard,J.F., 1990

Syncope and Presyncope Associated with Probable Adverse Drug Reactions
Arch Int Med 150:2309-2312, Hanlon,J.T.,et al, 1990

Bromocriptine-Induced Hypothermia
Neurol 40:383, Pfeiffer,R.F., 1990

Subcutaneous Apomorphine in the Treatment of Parkinson's Disease
JNNP 53:96-101, Frankel,J.P.,et al, 1990

Nasogastric and Intravenous Infusions of (+) -4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's Disease
JNNP 53:102-105, 1990, Coleman,R.J.,et al, 1990

The Evolution of Oral Contraceptives Maximizing Efficacy, Minimizing Risks
Acta Obstet Gynecol Scand (Suppl) 152:7-12990., Hedon,B., 1990

"Endogenous"Benzodiazepine Activity in Body Fluids of Patients with Hepatic Encephalopathy
Lancet 336:81-83, Mullen,K.D.,et al, 1990

Treatment of Prolactin-Secreting Pituitary Macroadenomas with the Long-Acting Non-Ergot Dopamine Agonist CV 205-502
Ann Int Med 112:668-673, Vance,M.L.,et al, 1990

Acromegaly
NEJM 322:966-977, Melmed,S., 1990

Risks Associated with Giving Benzodiazepines to Patients with Acute Neurological Injuries
BMJ 300:1189-1190, Eldridge,P.R.&Punt,J.A.G., 1990

Diagnostic Utility of Flumazenil in Coma with Suspected Poisoning:A Double Blind, Randomized Controlled Study
BMJ 301:1308-1311, Hojer,J.,et al, 1990

Optimizing Contraceptive Decisions:Clinical Implications of the Triphasic Randomized Clinical Trial
Am J Obstet Gynecol 161:1385-1389, Mishell,D.R., 1989

Bromocriptine in Parkinson's Disease:A Double-Blind Study Comparing"Low-Slow"and"High-Fast"in de Novo Patients
UK Bromocriptine Res Group, JNNP 52:77-821989., , 1989

Lisuride, A Dopamine Agonist in the Treatment of Early Parkinson's Disease
Neurol 39:336-339, Rinne,U.K., 1989

Delirium in the Elderly Patient
NEJM 320:578-582, Lipowski,Z.J., 1989

Clonidine Treatment of Alzheimer's Disease
Arch Neurol 46:376-378, Mohr,E.,et al, 1989

Pergolide and Selegiline for Parkinson's Disease
The Medical Letter, 31:81-841989., , 1989

Agonist Substitution in Advanced Parkinson's Disease
Neurol 39:1121-1122, Goetz,C.G.,et al, 1989

The Efficacy of (+) -4-Propyl-9-Hydroxynaphthoxazine as Adjunctive Therapy in Parkinson's Disease
JNNP 52:732-735, Weiner,W.J.,et al, 1989

Neuroleptic Malignant Syndrome, Review of Response to Therapy
Arch Int Med 149:1927-1931, Rosenberg,M.R.&Green,M., 1989

Drugs Acting on 5-Hydroxytryptamine Receptors
Editorial, Lancet 2:717-7191989., , 1989

MR of Deep Cerebral Venous Thrombosis
Can J Neurol Sci 16:417-421, Ashforth,R.A.,et al, 1989



Showing articles 300 to 350 of 488 << Previous Next >>